Trial intelligence / Profile preview

Safety and Immunogenicity of Adjuvanted Influenza Vaccine (2007-2008) in Adults and Elderly

NCT00518726Phase 2Completed

Sponsor
Novartis
Start
Jun 2007
Primary completion
Jul 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of influenza vaccine in influenza, sponsored by Novartis. Started Jun 2007; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00518726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00518726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call